Explore

Trendline Trendline
NN Inc. Reports Strong Q1 2026 Earnings, Raises Full-Year Guidance

NN Inc. Reports Strong Q1 2026 Earnings, Raises Full-Year Guidance

NN Inc. Reports Strong Q1 2026 Earnings, Raises Full-Year Guidance
Trendline Trendline
NN Inc. Reports Strong Q1 2026 Earnings with Significant Growth in Key Markets

NN Inc. Reports Strong Q1 2026 Earnings with Significant Growth in Key Markets

NN Inc. Reports Strong Q1 2026 Earnings with Significant Growth in Key Markets
Trendline Trendline
Freshpet Inc. Navigates Growth Amid Rising Costs in Q1 Earnings Call

Freshpet Inc. Navigates Growth Amid Rising Costs in Q1 Earnings Call

Freshpet Inc. Navigates Growth Amid Rising Costs in Q1 Earnings Call
Trendline Trendline
Qnity Electronics Set to Report Earnings Amid High Expectations and Economic Data Releases

Qnity Electronics Set to Report Earnings Amid High Expectations and Economic Data Releases

Qnity Electronics Set to Report Earnings Amid High Expectations and Economic Data Releases
Trendline Trendline
Hain Celestial Reports Q3 2026 Financial Results with Debt Reduction

Hain Celestial Reports Q3 2026 Financial Results with Debt Reduction

Hain Celestial Reports Q3 2026 Financial Results with Debt Reduction
Trendline Trendline
McKesson Reports Q1 Revenue Miss Amidst Margin Initiatives

McKesson Reports Q1 Revenue Miss Amidst Margin Initiatives

McKesson Reports Q1 Revenue Miss Amidst Margin Initiatives
Trendline Trendline
Global Partners Reports $70.1 Million Net Income in First Quarter of 2026

Global Partners Reports $70.1 Million Net Income in First Quarter of 2026

Global Partners Reports $70.1 Million Net Income in First Quarter of 2026
Trendline Trendline
Viatris to Present at 2026 Bank of America Healthcare Conference

Viatris to Present at 2026 Bank of America Healthcare Conference

Viatris to Present at 2026 Bank of America Healthcare Conference
Trendline Trendline
Verastem Oncology Reports $18.7 Million Revenue in Q1 2026 Amid New Clinical Trials

Verastem Oncology Reports $18.7 Million Revenue in Q1 2026 Amid New Clinical Trials

Verastem Oncology Reports $18.7 Million Revenue in Q1 2026 Amid New Clinical Trials
Trendline Trendline
Koppers Reports Improved First Quarter 2026 Financial Results Amid Market Challenges

Koppers Reports Improved First Quarter 2026 Financial Results Amid Market Challenges

Koppers Reports Improved First Quarter 2026 Financial Results Amid Market Challenges
Trendline Trendline
Century Casinos Reports Record First Quarter Revenue Amidst Strong North American Performance

Century Casinos Reports Record First Quarter Revenue Amidst Strong North American Performance

Century Casinos Reports Record First Quarter Revenue Amidst Strong North American Performance
Trendline Trendline
CrossAmerica Reports Record Adjusted EBITDA in First Quarter 2026 Amid Strategic Initiatives

CrossAmerica Reports Record Adjusted EBITDA in First Quarter 2026 Amid Strategic Initiatives

CrossAmerica Reports Record Adjusted EBITDA in First Quarter 2026 Amid Strategic Initiatives